Amicus Therapeutics Inc. buy UBS Group AG
Start price
10.05.24
/
50%
€8.60
Target price
10.05.25
€17.63
Performance (%)
-37.79%
End price
11.05.25
€5.35
Summary
This prediction ended on 11.05.25 with a price of €5.35. Massive losses of -37.79% were the result for the BUY prediction by UBS_Group_AG. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -0.800% | -0.800% | 55.975% |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % |
Comments by UBS_Group_AG for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at UBS Group AG from $20.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
02.03.23
02.03.23
€16.05
02.03.24
02.03.24
0.83%
03.03.24
03.03.24
